Convergence in medicine
With this seminar we want to strengthen the collaboration between UiO and OUS even further and hopefully inspire even more researchers to collaborate across disciplines and join in the next UiO:Life Science application round for convergence environments that will start in the spring of 2018
Registration from 12:30 PM
Main target groups: Researchers and students at UiO, OUS and Ahus.
Fill out the form at the bottom of the page to sign up.
In the spring 2017 UiO:Life Science appointed the first convergence environments – interdisciplinary research groups that will solve grand challenges. In three of the groups there is close collaboration between UiO and Oslo University Hospital (OUS). At this seminar you will hear short talks from different disciplines within the convergence environments. Also, each environment has invited an international speaker in the front of their research fields.
We hope that the current convergence environments will inspire more researchers from UiO and affiliated researchers at OUS and Akershus University Hospital (Ahus) to join the next application round for convergence enviroments.
Talks and 1–2 breaks
Professor Hilde Nebb, Deputy chair of the board UiO:Life Science and Deputy dean of research, the Faculty of Medicine, UiO
Personalised cancer therapies
Professor Trevor Graham:
Barts Cancer Institute UK
Predicting cancer evolution
Three short presentations form the convergence environment Personalised cancer therapies (PERCATHE)
The convergence environment will develop a new approach to personalised cancer therapy, based on mathematical, statistical and biological methods. It will also study the ethical, societal and regulatory perspectives.
Professor Arnoldo Frigessi, background for the convergence environment and the biostatistical perspectives.
Institute of Basic Medical Sciences, Faculty of Medicine, director of Oslo Centre for Biostatistics and Epidemiology (OCBE), UiO/OUS
Anne Kjersti Befring, the law perspectives
Doctoral Research Fellow, Department of Public and International Law, the Faculty of Law, UiO
Professor Kjetil Tasken, the biological and clinical perspectives
Director Centre for Molecular Medicine Norway (NCMM), the Faculty of Medicine, UiO. Head and Director of Institute for Cancer Research Oslo University Hospital (OUH) from 1 January 2018.
Organ on a chip and nano-devices
Dr. Peter Loskill: Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Germany
Stem cell based microphysiological Organ-on-a-Chip systems as in vitro models of human tissue
Three short presentations form the convergence environment Organ on a chip and nano-devices (CHIP)
The convergence environment will develop an “Organ on a chip” interface. This will provide a powerful new platform for understanding and testing of physiological functions and therapeutic interventions.
- Read more about the convergence environment.
This environment is a part of a Centre of Excellence (CoE) with funding from the Research Council of Norway
Professor Stefan Krauss , the background for the convergence environment and the biological perspectives,
Department of Molecular Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, UiO, and Oslo University Hospital (OUS)
Professor Ørjan Grøttem Martinsen, the electronics perspective:
Linear and non-linear electrical properties of biomaterials
Dr. Hanne Scholtz, the clinical perspectives
Division of surgery, inflammatory medicine and transplantation, OUS
Epigenetics and bioethics of human embryonic development
Professor Mary Herbert, Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, UK
Preventing germline transmission of mitochondrial DNA mutations – therapeutic potential and ethical considerations
Three short presentations from the convergence environment Epigenetics and bioethics of human embryonic development
The convergence environment wants to understand the epigenetic reprogramming of early embryo development and its significance for human reproduction both scientifically and ethically. An overarching theme will be the understanding of epigenetic information in the passing of life from one generation of humans to the next.
Professor II Arne Klungland, background for the convergence environment and the biological perspectives
Institute of Basic Medical Sciences, Faculty of Medicine, UiO, and Clinic for Laboratory Medicine (KLM), Oslo University Hospital (OUS)
Associate Professor, Anna Smajor, the ethical perspectives
Department of Philosophy, Classics, History of Art and Ideas, Faculty of Humanities, UiO
Professor II, Péter Fedorcsák,the clinical perspectives
Institute of Clinical Medicine, Faculty of Medicine, UiO, and Department of Reproductive Medicine, OUS